Abstract
This prospective study was conducted to report the effect of oral factor Xa inhibitor and low-molecular-weight heparin (LMWH) on surgical complications following total hip arthroplasty (THA). The patients with an age < 60 years were randomly assigned to three groups (rivaroxaban, enoxaparin, and placebo) and the patients with an age ≥ 60 years were assigned to two groups (rivaroxaban and enoxaparin). All drug regimens started at 12 hours postoperatively and continued for two weeks after surgery. Primary measure outcome was major surgical wound complications defined as haematoma requiring any intervention, superficial wound infection, deep periprosthetic infection, and increased wound bleeding. Secondary measured outcome included minor surgical complications (swelling, drainage, erythema, and oozing), organ bleeding, and venous thromboembolic (VTE) events. A total of 184 patients aged < 60 years and 167 patients aged ≥ 60 years were included as the analysis population per group. Up to 14 days after surgery, the overall incidence of major surgical complications associated with thromboprophylaxis was 6.5 % (58/886). There were no significant differences in the rate of major surgical complications among all the three groups of the ...Continue Reading
References
Sep 24, 2004·Chest·William H GeertsJoel G Ray
Oct 6, 2005·The Journal of Bone and Joint Surgery. American Volume·Clifford W ColwellUNKNOWN EXULT B Study Group
Sep 4, 2007·Journal of Thrombosis and Haemostasis : JTH·B I ErikssonUNKNOWN RE-MODEL Study Group
Sep 18, 2007·Lancet·Bengt I ErikssonUNKNOWN RE-NOVATE Study Group
Jul 24, 2008·Chest·William H GeertsClifford W Colwell
Jun 27, 2008·The New England Journal of Medicine·Bengt I ErikssonUNKNOWN RECORD1 Study Group
Jun 27, 2008·The New England Journal of Medicine·Michael R LassenUNKNOWN RECORD3 Investigators
Jun 28, 2008·Lancet·Ajay K KakkarUNKNOWN RECORD2 Investigators
Nov 15, 2008·Clinical Orthopaedics and Related Research·Panagiotis KoulouvarisNigel E Sharrock
May 5, 2009·Lancet·Alexander G G TurpieUNKNOWN RECORD4 Investigators
Aug 7, 2009·The New England Journal of Medicine·Michael Rud LassenRonald J Portman
Mar 3, 2010·The Journal of Bone and Joint Surgery. American Volume·Clifford W ColwellDouglas E Padgett
Mar 9, 2010·Lancet·Michael Rud LassenUNKNOWN ADVANCE-2 investigators
Jul 1, 2010·Journal of Thrombosis and Haemostasis : JTH·O E DahlJ W Eikelboom
Dec 24, 2010·The New England Journal of Medicine·Michael Rud LassenUNKNOWN ADVANCE-3 Investigators
Jan 5, 2011·The Journal of Bone and Joint Surgery. British Volume·C D JensenS D Muller
Nov 26, 2011·Hip International : the Journal of Clinical and Experimental Research on Hip Pathology and Therapy·Sukhdeep K GillJohn P Ivory
Dec 3, 2011·The Journal of the American Academy of Orthopaedic Surgeons·Michael A MontUNKNOWN AAOS
Dec 22, 2011·Thrombosis and Haemostasis·David BergqvistUNKNOWN ETHOS investigators
Dec 22, 2011·Thrombosis and Haemostasis·David BergqvistUNKNOWN ETHOS investigators
Feb 15, 2012·Chest·Yngve Falck-YtterClifford W Colwell
Mar 14, 2012·Annals of Internal Medicine·Diana M SobierajC Michael White
Jun 30, 2012·Pharmacotherapy·Diana M SobierajC Michael White
Nov 13, 2012·Current Vascular Pharmacology·Mohammed As-SultanyEleftherios Tsiridis
Oct 12, 2013·International Orthopaedics·Plamen KinovGershon Volpin
Jan 8, 2014·The Bone & Joint Journal·B V BlochA J Best
Citations
Aug 29, 2018·The Journal of the American Academy of Orthopaedic Surgeons·Harpreet BawaHue H Luu
Nov 6, 2018·Postgraduate Medicine·A Al-HillanD S Kountz
Jan 3, 2019·JBJS Reviews·Nikunj N TrivediGlenn D Wera
Apr 17, 2019·ANZ Journal of Surgery·Sinan NadiMaroeska Rovers
Sep 9, 2018·BMC Musculoskeletal Disorders·Xin Lu, Jin Lin
Dec 4, 2019·Blood Advances·David R AndersonPhilipp Dahm
Jan 11, 2021·Thrombosis Research·Tarek HaykalThomas L Ortel
Jun 20, 2021·International Journal of Clinical Practice·Mohannad Ali HasanJameel Tahseen Mehsen